Regeneron Pharmaceuticals Uncategorized Contracts & Agreements
50 Contracts & Agreements
- Amendment No (Filed With SEC on May 2, 2024)
- Amendment No. 1 to Master Agreement, dated as of April 10, 2023, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 3, 2023)
- Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)
- Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on November 5, 2020)
- Base Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on November 5, 2020)
- Amendment to the Amended and Restated Investor Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis US LLC, and Aventisub LLC (Filed With SEC on May 29, 2020)
- Second Amendment Agreement, dated December 19, 2019, by and between Bayer HealthCare LLC and the Registrant (Filed With SEC on February 7, 2020)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 7, 2020)
- Master Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
- Investor Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
- Letter Agreement, dated as of January 7, 2018, by and among Regeneron Pharmaceuticals, Inc., Sanofi, sanofi-aventis US LLC, Aventis Pharmaceuticals Inc., sanofi-aventis Amrique du... (Filed With SEC on May 3, 2018)
- CONSENT AND AMENDMENT NO. 1 MEMORANDUM (Filed With SEC on February 7, 2017)
- VestType (Filed With SEC on February 11, 2016)
- VestType (Filed With SEC on February 11, 2016)
- ID: [ ] Notice of Grant of Award 777 Old Saw Mill River Road And Award Agreement Tarrytown, New York 10591 [NAME] Award Number: [ ] [ADDRESS] Plan: [ ] (Filed With SEC on November 19, 2015)
- Vest Type (Filed With SEC on November 19, 2015)
- Vest Type (Filed With SEC on November 19, 2015)
- Annex A Unwind Period PriceAmendment Payment Amount per Warrant$370.00$273.46$375.00$278.44$380.00$283.43$385.00$288.41$390.00$293.40$395.00$298.38$397.75$301.07 (Filed With SEC on February 12, 2015)
- RESTATED AMENDMENT AGREEMENT (Filed With SEC on February 12, 2015)
- Amendment, dated as of May 16, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,... (Filed With SEC on August 5, 2014)
- Amendment, dated as of May 15, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,... (Filed With SEC on August 5, 2014)
- Amendment, dated as of May 13, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,... (Filed With SEC on August 5, 2014)
- AMENDED AND RESTATED INVESTOR AGREEMENT By and Among SANOFI, SANOFI-AVENTIS US LLC, AVENTIS PHARMACEUTICALS INC., SANOFI-AVENTIS AMÉRIQUE DU NORD AND REGENERONPHARMACEUTICALS,... (Filed With SEC on January 13, 2014)
- Annexe 1 (Filed With SEC on August 6, 2013)
- [SANOFI LETTERHEAD] (Filed With SEC on August 6, 2013)
- AMENDMENT AGREEMENT (Filed With SEC on July 25, 2012)
- MASTER TERMS AND CONDITIONS FOR BASE ADDITIONALWARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN MORGAN STANLEY & CO. INTERNATIONAL PLC AND REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN CITIBANK, N.A. AND REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN GOLDMAN, SACHS & CO. AND REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- SIXTH AMENDMENT TOLEASE (Filed With SEC on July 28, 2010)
- First Amendment to the InvestorAgreement dated as of December 20, 2007 (Filed With SEC on February 18, 2010)
- THIRD AMENDMENT TOLEASE (Filed With SEC on April 30, 2009)
- REGENERON PHARMACEUTICALS,INC. OPTION AGREEMENT PURSUANT TO THE 2000 LONG-TERMINCENTIVE PLAN (Filed With SEC on April 30, 2009)
- REGENERON PHARMACEUTICALS, INC. (Filed With SEC on June 17, 2008)
- INVESTOR AGREEMENT (Filed With SEC on February 27, 2008)
- EX-10.02: FORM OF OPTION AGREEMENT (Filed With SEC on December 16, 2005)
